Immune checkpoint protein VISTA can directly turn off T-cells during immunotherapy, study finds

FHS
May 17, 2024
6:23 pm

A Cleveland Clinic-led team of scientists and physicians have discovered that the immune checkpoint protein VISTA can directly turn off tumor-fighting T-cells during immunotherapy and resist treatment.

Centessa 2.0 with a twist: Medicxi combines six immuno-derm startups with $100M

European biotech investor Medicxi is bringing six startups under one roof to form an immuno-dermatology drugmaker with 14 pipeline projects in a move reminiscent of

February 12, 2024

Pfizer’s net income drops 98% in Q2 2024

Pfizer’s diluted earnings per share saw a sharp decline to $0.01 from $0.41 in the same quarter of the previous year. Credit: Karolis Kavolelis/Shutterstock. Pfizer

July 31, 2024

Exercise unleashes anti-inflammatory power against autoimmune diseases

The impact of exercise training on reducing inflammation in adolescents and adults with autoimmune diseases.

February 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.